MCPIP1 Selectively Destabilizes Transcripts Associated with an Antiapoptotic Gene Expression Program in Breast Cancer Cells That Can Elicit Complete Tumor Regression

Cancer Research
Wenbao LuJianguo Liu

Abstract

The ability of cancer cells to evade apoptosis is dictated by a shift in the balance between proapoptotic and antiapoptotic gene expression programs. Monocyte chemotactic protein-induced protein 1 (MCPIP1) is a zinc-finger RNA binding protein with important roles in mediating inflammatory responses. Overexpression of MCPIP1 in different cancer cell types has been implicated in eliciting an antitumor response, but a direct role of MCPIP1 in apoptosis has not been established. In this study, we demonstrate that MCPIP1 functions as a potent tumor suppressor that induces apoptosis of breast tumor cells by selectively enhancing mRNA decay of antiapoptotic gene transcripts, including Bcl2L1, Bcl2A1, RelB, Birc3, and Bcl3. Mechanistically, MCPIP1 physically interacted with a stem-loop structure in the 3' untranslated region of these transcripts through its PIN domain, causing mRNA destabilization. Furthermore, we found that MCPIP1 expression was repressed in breast tumor cells, and overexpression of MCPIP1 induced apoptosis, whereas its depletion enhanced cancer cell proliferation. Moreover, MCPIP1 induction in vivo resulted in complete regression of established tumors and a significant reduction in metastatic disease. Notably, low MC...Continue Reading

References

Mar 10, 1995·Science·H Steller
Feb 26, 2000·Carcinogenesis·S W Lowe, A W Lin
Feb 15, 2001·Endocrine-related Cancer·R KumarL Adam
May 11, 2002·Nature Reviews. Cancer·Frederik H Igney, Peter H Krammer
Jun 26, 2003·Nucleic Acids Research·Ivo L Hofacker
Sep 6, 2005·Proceedings of the National Academy of Sciences of the United States of America·Lance D MillerJonas Bergh
Jan 8, 2008·The Journal of Biological Chemistry·Jian LiangMingui Fu
Oct 29, 2008·Oncogene·K W Yip, J C Reed
Feb 21, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Min H Kang, C Patrick Reynolds
May 13, 2010·The Journal of Biological Chemistry·Toshio TandoHideo Iba
Dec 1, 2010·The Journal of Experimental Medicine·Jian LiangMingui Fu
Mar 8, 2011·Cell·Douglas Hanahan, Robert A Weinberg
Apr 26, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Xuesong QianJianguo Liu
Dec 27, 2011·Molecular Cancer·Vilma Maldonado, Jorge Melendez-Zajgla
Dec 29, 2011·Frontiers in Bioscience (Landmark Edition)·Sandhya SandujaDan A Dixon
Mar 6, 2012·Ageing Research Reviews·Christina R RossGerald M Wilson
Apr 5, 2013·Immunological Reviews·Pavel Ivanov, Paul Anderson
Apr 5, 2013·The FEBS Journal·Lukasz SkalniakJolanta Jura
Apr 13, 2013·Arteriosclerosis, Thrombosis, and Vascular Biology·Ming HeZuyi Yuan
May 7, 2013·The Journal of Immunology : Official Journal of the American Association of Immunologists·Xuesong QianJianguo Liu
Oct 5, 2013·Cell Death & Disease·J M EichhornT C Chambers
Nov 6, 2013·Proceedings of the National Academy of Sciences of the United States of America·Shufeng LiuTianyi Wang
Apr 5, 2014·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Irina Vlasova-St Louis, Paul R Bohjanen
Sep 5, 2014·Journal of Cellular Biochemistry·Ji Hyo LyuSuk-Hwan Baek
Sep 17, 2014·The Journal of Immunology : Official Journal of the American Association of Immunologists·Ren-Jye LinShyr-Yi Lin

❮ Previous
Next ❯

Citations

Apr 14, 2016·Expert Review of Clinical Immunology·Andrea GuennounDavide Bedognetti
May 6, 2016·Expert Opinion on Emerging Drugs·Douglas B JohnsonJeffrey A Sosman
Mar 18, 2017·Nature Communications·Yan ZhangHermann Brenner
Mar 23, 2017·PloS One·Barbara LipertJolanta Jura
Dec 10, 2016·Journal of Cellular Biochemistry·Elżbieta BoratynHanna Rokita
Apr 17, 2019·RNA·Mateusz WawroAneta Kasza
Nov 14, 2019·Cancer Biology & Therapy·Zhaozhou RenQin Fu
Jan 11, 2020·Journal of Cellular Biochemistry·Elżbieta BoratynHanna Rokita
May 21, 2019·Oncoscience·Tao ChenYuexin Liu
May 28, 2019·The Journal of Experimental Medicine·Matthias von GammElke Glasmacher
Feb 15, 2017·Cellular & Molecular Immunology·Renfang MaoYihui Fan
Mar 2, 2018·Oncotarget·Agata Lichawska-CieslarJolanta Jura
Oct 23, 2019·Journal of Experimental & Clinical Cancer Research : CR·Katarzyna MiekusJolanta Jura
Feb 16, 2017·Angiogenesis·Janusz LigezaJolanta Jura
May 11, 2018·Scientific Reports·Mateusz WilamowskiJolanta Jura
Oct 3, 2020·International Journal of Molecular Sciences·Richard MussonJolanta Jura
Jul 13, 2020·Journal of Hematology & Oncology·Hai QinLufeng Zheng
Jan 29, 2020·JCI Insight·Kazufumi MatsushitaTomohiro Yoshimoto
Nov 11, 2019·Trends in Cancer·Daniela MennerichThomas Kietzmann
Jan 9, 2021·Cell & Bioscience·Raffaele Frazzi
Mar 16, 2021·Frontiers in Immunology·Ewelina DoboszJoanna Koziel
Nov 19, 2020·Journal of Proteome Research·Keun NaYoung-Ki Paik

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Related Papers

Annals of the New York Academy of Sciences
Simone Fulda, Klaus-Michael Debatin
Current Opinion in Pharmacology
Simone Fulda, Klaus-Michael Debatin
© 2021 Meta ULC. All rights reserved